The Global Cell-based Assays Market is Estimated to reach $24.9 Billion by 2028, at a CAGR of 8.2%

Published Date: 31-Oct-2022

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

Cell-based Assays Market Growth, Trends and Report Highlights

According to a new report, published by KBV research, The Global Cell-based Assays Market size is expected to reach $24.9 billion by 2028, rising at a market growth of 8.2% CAGR during the forecast period.

The Drug Discovery market is leading the Global Cell-based Assays Market by Application in 2021; thereby, achieving a market value of $11.9 billion by 2028. This expansion can be attributed to the increasing need for novel therapeutic medications all over the world, which are used in the treatment of a wide variety of ailments. An increase in the number of research and studies for therapeutic drug development and competitive pressures for FDA approvals among market competitors are both factors that are contributing to the expansion of the drug discovery market sector.

The Academic & Research Institutes market is experiencing a CAGR of 8.4% during (2022 - 2028). This expansion can be ascribed to a number of factors, including the growing use of these assays in cell-based research as well as the development of innovative assay-based diagnostics. In addition, cell-based assays foster research in a variety of fields, including cancer, stem cells, immunology, and immunology, amongst others. Due to these factors, the growth of this segment is being accelerated.

The Reagents market is anticipated to witness a CAGR of 9% during (2022 - 2028). Any chemical reaction requires the use of something called a reagent. It is a very integral part of any chemical experiment. A chemical or compound that has the ability to aid a reaction is referred to as a reagent. Reagents are utilized in the majority of tests that are performed. This encompasses a wide range of diagnostic tools, such as blood glucose tests, pregnancy tests, and the majority of COVID-19 test kits.

The North America market dominated the Global Cell-based Assays Market by Region in 2021; thereby, achieving a market value of $9.9 billion by 2028. The Europe market is poised a CAGR of 7.7% during (2022 - 2028). Additionally, The Asia Pacific market would witness a CAGR of 9% during (2022 - 2028).

Full Report: https://www.kbvresearch.com/cell-based-assays-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Corning Incorporated, Charles River Laboratories International, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Lonza Group AG, Merck Group, Promega Corporation and Thermo Fisher Scientific, Inc.

Global Cell-based Assays Market Segmentation

By Application

  • Drug Discovery
  • Basic Research
  • Others

By End User

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Contract Research Organizations (CROs)

By Products & Services

  • Assay Kits
  • Reagents
  • Microplates
  • Probes & Labels
  • Instruments & Software
  • Cell Lines

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Corning Incorporated
  • Charles River Laboratories International, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Lonza Group AG
  • Merck Group
  • Promega Corporation
  • Thermo Fisher Scientific, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Related Reports:

North America Cell-based Assays Market size & Opportunities 2022-2028

Europe Cell-based Assays Market & Growth Forecast 2022-2028

Asia Pacific Cell-based Assays Market Share & Industry Outlook to 2028

LAMEA Cell-based Assays Market Growth, Trends & Forecasts 2022-2028

Request a Free Sample Copy


Why Choose Us

  • 24/7 Research support
    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Information security
    Your personal and confidential information is safe and secure.